InvestorsHub Logo
Followers 12
Posts 616
Boards Moderated 0
Alias Born 05/06/2016

Re: woodenbear post# 16350

Wednesday, 08/02/2017 4:43:41 PM

Wednesday, August 02, 2017 4:43:41 PM

Post# of 233768
I think ideally the company would like to bring mono across the finish line because that is the real money maker. However, you're talking about a pre-revenue biotech that will have to continue to dilute to raise funds to see this thing through. Additionally, the company does not have the staff or resources to bring the drug to market themselves. I think the strategy is complete as much of the trials as possible and hope for a bidding war amongst the big pharma Giants.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News